JESSICA BREMM: Open Payments
NPI 1538549613 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$467 in 10 payments from 6 companies in 2025. Trend: 2023 $1,848 · 2024 $1,191 · 2025 $467
Food & beverage: $467
| Company | Payments | Amount |
|---|---|---|
| Janssen Scientific Affairs, LLC | 1 | $142 |
| Janssen Biotech, Inc. | 1 | $121 |
| Novartis Pharmaceuticals Corporation | 3 | $78 |
| ABBVIE INC. | 3 | $78 |
| Gilead Sciences, Inc. | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $20 |
Products named: ERLEADA, RYBREVANT, VENCLEXTA, LUTATHERA, KISQALI, Trodelvy, IMBRUVICA, JEMPERLI.
Industry payments across FL — which companies pay providers there.
